ABOUT US

We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

More About Us

...working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.

James M Mackay, President and Chief Executive Officer, Aristea Therapeutics

RESOURCE CENTER

FDA GUIDANCE ON COVID-19 VACCINES (BLOG/PODCAST)

Read the blog

FDA Guidance on COVID-19 Vaccines (blog/podcast)

The U.S. FDA issued Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry to provide its perspective on (and recommendations) for the CMC (chemistry, manufacturing, and control), nonclinical, and clinical aspects related to such vaccines.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Careers

Join our team! Work at Altasciences - View all clinical job postings

Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.

Learn More

NEWS & EVENTS

WEBINAR - Navigating Early Phase CNS-Active Drug Development with Dr. Beatrice Setnik, CSO

Webinar

WEBINAR - Navigating Early Phase CNS-Active Drug Development with Dr. Beatrice Setnik, CSO

Sep 22, 2020

As you work towards a successful New Drug Application (NDA) submission, there are many considerations that must be taken into account, specifically for CNS-active drugs.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Our Solutions

Scientific Publications

Read the blog

FDA Guidance on COVID-19 Vaccines (blog/podcast)

The U.S. FDA issued Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry to provide its perspective on (and recommendations) for the CMC (chemistry, manufacturing, and control), nonclinical, and clinical aspects related to such vaccines.

Read the blog

SELECT A CATEGORY BELOW

SCIENTIFIC PUBLICATIONS

Working as a flexible, attentive extension of your team, we offer all you need to move your molecule forward.

Send Us A Message

STAY CONNECTED

2019 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy